Lupus & antiphospholipid syndrome
Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus
Authors' conclusion
We provide further evidence to support the feasibility, acceptability, and fidelity of the adherence intervention.
Study context
- Population
- Nonadherent patients with systemic lupus erythematosus (SLE) (90-day PDC < 80% for SLE medications) and their clinicians
- Participants
- 25 encounters
- Outcome
- Implementation of clinician-led adherence intervention
Methodological detailsaudio-recorded encounters, semistructured interviews
- Audio-recorded encounters
- Semistructured interviews
Main finding
As reported in the abstract
Average duration of adherence discussions (minutes)
3.8
Patients with ≥ 20% increase in PDC post intervention
44%
Original publication
Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus. J Rheumatol. Published 1 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →